Immunology
-
A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques
This article has 14 authors:Reviewed by ScreenIT
-
Activin A correlates with the worst outcomes in COVID-19 patients, and can be induced by cytokines via the IKK/NF-kappa B pathway
This article has 13 authors:Reviewed by ScreenIT
-
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants
This article has 27 authors:Reviewed by ScreenIT
-
Single-Domain SARS-CoV-2 S1 and RBD Antibodies Isolated from Immunized Llama Effectively Bind Targets of the Wuhan, UK, and South African Strains in vitro
This article has 10 authors:Reviewed by ScreenIT
-
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants
This article has 17 authors:Reviewed by ScreenIT
-
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody
This article has 46 authors:Reviewed by ScreenIT
-
Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
This article has 13 authors:Reviewed by ScreenIT
-
Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein
This article has 15 authors:Reviewed by ScreenIT
-
A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection
This article has 14 authors:Reviewed by ScreenIT
-
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors
This article has 28 authors:Reviewed by ScreenIT